United States — Centers for Disease Control and Prevention & Kyle Diamantas

United States — Centers for Disease Control and Prevention: The CDC tracked the outbreak, reporting thousands of cases and issuing health alerts. It faced scrutiny over reduced surveillance due to budget cuts, which may have hampered response.

Kyle Diamantas: Acting FDA Commissioner Kyle Diamantas announced the false-positive test result, which complicated the investigation.

United States — Centers for Disease Control and Prevention: CDC data on ultraprocessed food consumption provides context for the rule, but the agency is not directly affected.

Kyle Diamantas: As acting FDA Commissioner, Diamantas is the public face of the proposal, articulating its benefits for postmarket safety.

United States — Centers for Disease Control and Prevention: CDC's advisory committee may recommend mFLUSIVA, which would influence coverage and uptake; its recommendation is pending.

Kyle Diamantas: As acting FDA Commissioner, Diamantas sought to rebuild industry confidence after the controversies.

United States — Centers for Disease Control and Prevention: CDC is a separate agency; its leadership changes are part of the broader health turmoil but not directly impacted.

Kyle Diamantas: Diamantas has been acting FDA chief since May, providing some stability. His future role is uncertain under a new commissioner.

Kyle Diamantas: Kyle Diamantas, the United States — Food and Drug Administration's deputy commissioner for foods, is tasked with developing a definition for 'ultra-processed foods' and is the first non-scientist to head the United States — Food and Drug Administration in over half a century, raising concerns among critics.

Kyle Diamantas: Kyle Diamantas will serve as the acting commissioner of the United States — Food and Drug Administration following Marty Makary's resignation, suggesting a potential shift in the agency's approach to various regulatory issues.